Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

ProQR Therapeutics N.V (PRQR) Debt Ratio: 2021-2025

Historic Debt Ratio for ProQR Therapeutics N.V (PRQR) over the last 3 years, with Sep 2025 value amounting to 0.04.

  • ProQR Therapeutics N.V's Debt Ratio rose 191.45% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year increase of 191.45%. This contributed to the annual value of 0.05 for FY2024, which is 175181.22% up from last year.
  • As of Q3 2025, ProQR Therapeutics N.V's Debt Ratio stood at 0.04, which was down 99.89% from 34.37 recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Debt Ratio ranged from a high of 54.56 in Q4 2024 and a low of -37.59 during Q2 2024.
  • Its 3-year average for Debt Ratio is 4.68, with a median of 0.02 in 2023.
  • Over the last 5 years, ProQR Therapeutics N.V's Debt Ratio had its largest YoY gain of 175,181.22% in 2024, and its largest YoY loss of 155,687.99% in 2024.
  • Over the past 5 years, ProQR Therapeutics N.V's Debt Ratio (Quarterly) stood at 0.21 in 2021, then crashed by 81.21% to 0.04 in 2022, then declined by 21.24% to 0.03 in 2023, then spiked by 175,181.22% to 54.56 in 2024, then spiked by 191.45% to 0.04 in 2025.
  • Its last three reported values are 0.04 in Q3 2025, 34.37 for Q2 2025, and 0.03 during Q1 2025.